Central nervous system regulation of energy metabolism: Ghrelin versus leptin

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 14-19

  Nogueiras, Ruben ^a   Tschöp, Matthias H ^a,b   Zigman, Jeffrey M ^c,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Central nervous system; Energy balance equation; Energy partitioning; Ghrelin; Leptin; Melanocortin

Indexed keywords

GHRELIN; GLUCOSE; HORMONE; LEPTIN; LIPID;

ARCUATE NUCLEUS; BODY WEIGHT; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DIABETES MELLITUS; ENERGY BALANCE; ENERGY METABOLISM; FEEDING BEHAVIOR; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; NONHUMAN; OBESITY; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 42549165949     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.054     Document Type: Conference Paper

References (40)

1. 1 Kojima, M., H. Hosoda, Y. Date, et al. 1999. Ghrelin is a growth‐hormone‐releasing acylated peptide from stomach. Nature 402: 656–660.
2. 2 Van Der Lely, A.J., M. Tschop, M.L. Heiman & E. Ghigo. 2004. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25: 426–457.
3. 3 Dezaki, K., H. Hosoda, M. Kakei, et al. 2004. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta‐cells: implication in the glycemic control in rodents. Diabetes 53: 3142–3151.
4. 4 Sun, Y., M. Asnicar, P.K. Saha, et al. 2006. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 3: 379–386.
5. 5 Nakazato, M., N. Murakami, Y. Date, et al. 2001. A role for ghrelin in the central regulation of feeding. Nature 409: 194–198.
6. 6 Asakawa, A., A. Inui, T. Kaga, et al. 2001. Ghrelin is an appetite‐stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337–345.
7. 7 Tschop, M., D.L. Smiley & M.L. Heiman. 2000. Ghrelin induces adiposity in rodents. Nature 407: 908–913.
8. 8 Theander‐Carrillo, C., P. Wiedmer, P. Cettour‐Rose, et al. 2006. Ghrelin action in the brain controls adipocyte metabolism. J. Clin. Invest. 116: 1983–1993.
9. 9 Shimbara, T., M.S. Mondal, T. Kawagoe, et al. 2004. Central administration of ghrelin preferentially enhances fat ingestion. Neurosci. Lett. 369: 75–79.
10. 10 Cummings, D.E., J.Q. Purnell, R.S. Frayo, et al. 2001. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714–1719.
11. 11 Sun, Y., P. Wang, H. Zheng & R.G. Smith. 2004. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 101: 4679–4684.
12. 12 Zigman, J.M., Y. Nakano, R. Coppari, et al. 2005. Mice lacking ghrelin receptors resist the development of diet‐induced obesity. J. Clin. Invest. 115: 3564–3572.
13. 13 Sun, Y., S. Ahmed & R.G. Smith. 2003. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol. 23: 7973–7981.
14. 14 Wortley, K.E., J.P. Del Rincon, J.D. Murray, et al. 2005. Absence of ghrelin protects against early‐onset obesity. J. Clin. Invest. 115: 3573–3578.
15. 15 Shearman, L.P., S.P. Wang, S. Helmling, et al. 2006. Ghrelin neutralization by a ribonucleic acid‐SPM ameliorates obesity in diet‐induced obese mice. Endocrinology 147: 1517–1526.
16. 16 Zorrilla, E.P., S. Iwasaki, J.A. Moss, et al. 2006. Vaccination against weight gain. Proc. Natl. Acad. Sci. USA 103: 13226–13231.
17. 17 Esler, W.P., J. Rudolph, T.H. Claus, et al. 2007. Small‐molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148: 5175–5185.
18. 18 Tschop, M., C. Weyer, P.A. Tataranni, et al. 2001. Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707–709.
19. 19 Ravussin, E., M. Tschop, S. Morales, et al. 2001. Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. J. Clin. Endocrinol. Metab. 86: 4547–4551.
20. 20 Hansen, T.K., R. Dall, H. Hosoda, et al. 2002. Weight loss increases circulating levels of ghrelin in human obesity. Clin. Endocrinol. (Oxf.) 56: 203–206.
21. 21 Otto, B., U. Cuntz, E. Fruehauf, et al. 2001. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145: 669–673.
22. 22 Cummings, D.E., K. Clement, J.Q. Purnell, et al. 2002. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med. 8: 643–644.
23. 23 Goldstone, A.P. 2004. Prader‐Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab. 15: 12–20.
24. 24 Hyman, S.E., R.C. Malenka & E.J. Nestler. 2006. Neural mechanisms of addiction: the role of reward‐related learning and memory. Annu. Rev. Neurosci. 29: 565–598.
25. 25 Zigman, J.M., J.E. Jones, C.E. Lee, et al. 2006. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 494: 528–548.
26. 26 Naleid, A.M., M.K. Grace, D.E. Cummings & A.S. Levine. 2005. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26: 2274–2279.
27. 27 Abizaid, A., Z.W. Liu, Z.B. Andrews, et al. 2006. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116: 3229–3239.
28. 28 Jerlhag, E., E. Egecioglu, S.L. Dickson, et al. 2006. Ghrelin stimulates locomotor activity and accumbal dopamine‐overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict. Biol. 11: 45–54.
29. 29 Zigman, J.M. & J.K. Elmquist. 2003. Minireview: from anorexia to obesity–the yin and yang of body weight control. Endocrinology 144: 3749–3756.
30. 30 Morton, G.J., D.E. Cummings, D.G. Baskin, et al. 2006. Central nervous system control of food intake and body weight. Nature 443: 289–295.
31. 31 Coleman, D.L. 1973. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9: 294–298.
32. 32 Zhang, Y., R. Proenca, M. Maffei, et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432.
33. 33 Tartaglia, L.A., M. Dembski, X. Weng, et al. 1995. Identification and expression cloning of a leptin receptor, OB‐R. Cell 83: 1263–1271.
34. 34 Obici, S., Z. Feng, J. Tan, et al. 2001. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108: 1079–1085.
35. 35 Coppari, R., M. Ichinose, C.E. Lee, et al. 2005. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab. 1: 63–72.
36. 36 Montague, C.T., I.S. Farooqi, J.P. Whitehead, et al. 1997. Congenital leptin deficiency is associated with severe early‐onset obesity in humans. Nature 387: 903–908.
37. 37 Farooqi, I.S., S.A. Jebb, G. Langmack, et al. 1999. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341: 879–884.
38. 38 Farooqi, I.S., E. Bullmore, J. Keogh, et al. 2007. Leptin regulates striatal regions and human eating behavior. Science 317: 1355.
39. 39 Clement, K., C. Vaisse, N. Lahlou, et al. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398–401.
40. 40 Farooqi, I.S., J.M. Keogh, G.S. Yeo, et al. 2003. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348: 1085–1095.